PRJNA577399
Correcting Smad1/5/8, mTOR, and VEGFR2 treats vascular pathology in hereditary hemorrhagic telangiectasia models
This project studied the liver transcripts differentially expressed by treatment with the drugs Nintedanib or Sirolimus in isolation (NIN or SIRO) and in combination (COMBO) when mice are treated with the drugs in vivo.